ArticleBritish journal of pharmacology2024

Intravenous recombinant cerebellin 1 treatment restores signalling by spinal glutamate delta 1 receptors and mitigates chronic pain.

Siddhesh S Sabnis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.